HIV Suicide Prevention With AI-DBT
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorRutgers, The State University of New Jersey
About this trial
One in four older persons living with HIV/AIDS (PLWHA) report at least one suicide attempt in their lifetime, and the risk for death by suicide is 100 times higher in PLWHA than in the general population. Currently, there are no behavioral interventions that specifically address suicide prevention for older PLWHA, despite their unique biopsychosocial and structural risk factors. Through this work, investigators will adapt Dialectical Behavior Therapy, an evidence-based intervention for suicide prevention, for patients with PLWHA to be delivered by an AI-powered conversational Agent developed by our industry partner, Empower Health. Investigators will then pilot test the feasibility, usability, acceptability and preliminary efficacy to improve self-efficacy to manage negative emotions in n=50 older adults living with HIV/AIDS.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Aged 50+
evidence of suicide risk as defined by at least one of the following: PHQ-9 suicide item > 0, Ask Suicide Questions (ASQ, an NIMH-supported suicide risk screener with a version tailored for primary care) > 0, expression of suicidal thoughts to the provider during appointment, a suicide attempt in the past year, or PHQ-9 total score ≥ 8,
ability to read and communicate fluently in English or Spanish
not at imminent risk for suicide (does not have significant intent to die within 48 hours)
Disqualifiers
deemed clinically inappropriate to participate because of severe psychosis, severe substance use, or severe cognitive deficits that would interfere with their comprehending study and intervention material.
Trial design
Design model
Parallel
Treatments tested in this trial
AI-DBT
BehavioralParticipants will receive 14, 5 minute videos delivered 2x/week that describe DBT skills and tools. They will also receive the option of engaging in coaching sessions.
Treatment groups
50 Participants
are divided into 2 treatment groupsGroup A: usual careNo intervention 0 interventions
Group B: AI-DBTExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Self-efficacy to manage emotions
Scale to determine if someone has self-efficacy to manage negative emotions
Time frame
baseline, 6 and 12 weeks for long-form.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Rutgers, The State University of New Jersey
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
Source ClinicalTrials.gov